Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?

i

Policy question - should vaccination with Pfizer-BioNTech COVID-19 vaccine (2-doses, IM) be recommended for persons 16 years of age and older under an emergency use authorization?

Public Domain

December 12, 2020
By United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
Series: ACIP: Coronavirus Disease 2019 (COVID-19)

File Language:

English

Details

Corporate Authors:

United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
Description:

COVID-04-VOTE-508.pdf
Subjects:

Coronavirus Infections/prevention & Control COVID-19 Pandemics Vaccination Viral Vaccines
Series:

ACIP: Coronavirus Disease 2019 (COVID-19)
Document Type:

Still Image
Name as Subject:

ACIP meeting: 2020 Dec 11 ; Pfizer-BioNTech COVID-19 Vaccine ; ACIP meeting: 2020 Dec 11 ; Pfizer-BioNTech COVID-19 Vaccine
Genre:

Presentation ; Conference Publications
Volume:

2000211
Issue:

020104
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha-512:142df82033a3b5875541c76f587004dd61f72b2c1e4d4435d1421809d441b6824631f0f978278b7c2f73bf5a2d1ba102109c16d6cfbfdc24e3d2581927ebc66c
Download URL:

https://stacks.cdc.gov/view/cdc/105437/cdc_105437_DS1.pdf
File Type:

[PDF - 287.45 KB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.